Zhang, L.; Zhang, F.; Liang, H.; Qin, X.; Liang, C.; Zhong, M.; Mo, Y.; Xie, J.; Hou, X.; Deng, J.;
et al. Identification of HMOX-1-Targeting Natural Compounds in Camellia nitidissima Chi for NSCLC Therapy: Integrating Bioassay and In Silico Screening Approaches. Pharmaceuticals 2025, 18, 824.
https://doi.org/10.3390/ph18060824
AMA Style
Zhang L, Zhang F, Liang H, Qin X, Liang C, Zhong M, Mo Y, Xie J, Hou X, Deng J,
et al. Identification of HMOX-1-Targeting Natural Compounds in Camellia nitidissima Chi for NSCLC Therapy: Integrating Bioassay and In Silico Screening Approaches. Pharmaceuticals. 2025; 18(6):824.
https://doi.org/10.3390/ph18060824
Chicago/Turabian Style
Zhang, Lingqiu, Fan Zhang, Haimei Liang, Xiangling Qin, Chunmei Liang, Manlu Zhong, Yuemi Mo, Jinling Xie, Xiaotao Hou, Jiagang Deng,
and et al. 2025. "Identification of HMOX-1-Targeting Natural Compounds in Camellia nitidissima Chi for NSCLC Therapy: Integrating Bioassay and In Silico Screening Approaches" Pharmaceuticals 18, no. 6: 824.
https://doi.org/10.3390/ph18060824
APA Style
Zhang, L., Zhang, F., Liang, H., Qin, X., Liang, C., Zhong, M., Mo, Y., Xie, J., Hou, X., Deng, J., Hao, E., & Du, Z.
(2025). Identification of HMOX-1-Targeting Natural Compounds in Camellia nitidissima Chi for NSCLC Therapy: Integrating Bioassay and In Silico Screening Approaches. Pharmaceuticals, 18(6), 824.
https://doi.org/10.3390/ph18060824